Ultrastructural changes in the respiratory zone of the lungs in the late stages of experimental Diabetes Mellitus
DOI:
https://doi.org/10.12775/JEHS.2025.86.67375Keywords
streptozotocin-induced diabetes, lungs, respiratory partAbstract
Background. Today, diabetes mellitus is one of the major challenges of modern medicine and is among the most widespread endocrine disorders. Our research aimed to study the dynamics of changes in the components of the respiratory part of the lungs in streptozotocin-induced diabetes. Materials and methods. The experiments were performed on 68 white male Wistar rats weighing 180-220 g. The animals were divided into three groups: 1 – intact (n=10); 2 - control (n=30); 3 - experimental (n=28) with a model of diabetes mellitus, which was reproduced by intraperitoneal injection of streptozotocin company "Sigma" (USA), diluted in 0.1 M citrate buffer with pH 4.5, at a rate of 60 mg/kg body weight. The control group of animals received an intraperitoneal injection with an equivalent dose of 0.1 M citrate buffer solution with a pH of 4.5.
Pulmonary tissue collection for electron microscopic examination was performed under thiopental anesthesia 56, 70 and 84 days after streptozotocin injection. Pieces of lung tissue were fixed in 2.5% glutaraldehyde solution, followed by fixation in 1% osmium tetroxide solution. After dehydration, the material was poured into epon-araldite. Sections obtained on an ultramicrotome "Tesla BS-490" were studied in an electron microscope «PEM-125K». All studies were performed under sodium thiopental anesthesia at the rate of 60 mg/kg of body weight. Results. Our research showed that 56, 70 and 84 days after the modeling of streptozotocin-induced diabetes changes of a dystrophic-destructive nature were noted in alveolocytes of types I and II, and endotheliocytes of hemocapillaries. At the same time, cells with increased functional activity were determined in the components of the respiratory part of the lungs. Conclusion. Streptozotocin-induced diabetes leads to severe violations of the ultrastructural organization of components of the respiratory part of the lungs. The nature and severity of structural changes in type I, II alveolocytes, and endotheliocytes of hemocapillaries depend on the duration of diabetes.
References
1. Chen X-F, Yan L-J, Lecube A, Tang X. Editorial: Diabetes and Obesity Effects on Lung Function. Fronties in Endocrinology. 2020;11(462):1-2. doi: 10.3389/fendo.2020.00462.
2. Grams M E, Rabb H.The distant organ effects of acute kidney injury. Kidney International. 2012;81:942-8. doi:10.1038/ki.2011.241.
3. Hu JF, Zhang GJ, Wang L, Kang PF, Li J, Wang HJ, et al. Ethanol at low concentration attenuates diabetes induced lung injury in rats model. J Diabetes Res, 2014: http://dx.doi.org/10.1155/2014/107152.
4. Husain-Syed F, Slutsky AS, Ronco C. Lung - kidney cross talk in the critically III patient. American journal of respiratory and critical care medicine.2016;194:402-14. doi: 10.1164/rccm.201602-0420cp.
5. Khateeb J, Fuchs E, Khamaisi M. Diabetes and Lung Disease: An Underestimated Relationship. The Review of Diabetic Studies. 2019;15:1-15. doi: 10.1900/RDS.2019.15.1.
6. Kuziemski K, Slominski W, Jassem E. Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy. BMC Endocrine disorders. 2019; 19:2. doi: 10.1186/s12902-018-0328-1.
7. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: global estimates lor the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi: 10.HH6/j.diabres.2017.03.024.
8. Oldham JM, Collard HR. Comorbid conditions in idiopathic pulmonary fibrosis:recognition and management. Frontiers in Medicine. 2017; 4:123. doi: 10.3389/fmed.2017.00123.
9. Rajasurya, V., Gunasekaran, K., & Surani, S. (2020). Interstitial lung disease and diabetes. World Journal of Diabetes, 11(8), 351-357. DOI: 10.4239/wjd.v11.i8.351.
10. Rani RE, Ebenezer BSI, Venkateswarlu M. A study on pulmonary function parameters in type 2 diabetes mellitus. National Journal of Physiology, Pharmacy and Pharmacology. 2019; 9(1):53–57. doi:10.5455/njppp.2019.0414713112018.
11. Riviello ED, Buregeya E, Twagirumugabe T. Diagnosing acute respirator distress syndrome in resource limited settings: the Kigali modification of the Berlin definition. Curr Opin Critt Care. 2017; 23:18-23. doi: 10.1097/MCC.0000000000000372.286
12. Simo R, Lecube A. Looking for solutions to lung dysfunction in type 2 diabetes. Ann Transl Med. 2020;8(8): 521. DOI: 10.21037/atm.2020.03.225
13. Sudy R, Schranc A, Fodor GH, Tolnai J, Babik B, Petak F. Lung volume dependence of respiratory function in rodent models of diabetes mellitus. Respiratory research. 2020;21:82. https://doi.org/10.1186/s12931-020-01334-y.
14. Sun XM, Tan JC, Zhu Y, Lin L. Association between diabetes mellitus and gastroesophageal reflux disease: a metaanalysis. World J Gastroenterol. 2015; 21(10):3085-3092. doi: 10.3748/wjg.v21.i10.3085.
15. Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immonol. 2014;16(1):27-35. doi:10.1038/ni.3045.
16. Zheng H, Wu J, Jin Z, Yan L-J. Potential biochemical mechanisms of lung injury in diabetes. Aging and disease. 2017;1(8):7-16. doi: 10.14336/AD.2016.0627.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Liubomyr Zaiats, Yaroslav Syniak, Walery Zukow

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 8
Number of citations: 0